The US Food and Drug Administration has approved Zepbound (tirzepatide) as the first prescription medication for the treatment of obstructive sleep apnea (OSA).
The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA).
Check out this year's top 5 pieces of sleep coverage that cover topics surveying the benefits of supplements, novel ...
Wall Street saw gains as the S&P 500 rose 0.7% and the Nasdaq climbed 1%, driven by tech and communications stocks. Despite ...
Stocks closed higher on Wall Street at the start of a holiday-shortened week. The S&P 500 rose 0.7% Monday. Several big ...
Honda and Nissan merger talks stir Wall Street, as tech stocks like Nvidia and Broadcom provide market support. Meanwhile, ...
“Today’s approval marks the first drug treatment option for certain patients with obstructive sleep apnea,” Dr. Sally Seymour ...
In our fast-paced world, people tend to multitask, making it challenging to absorb information. Here's when to consult a ...
Following the historic qualification of Jamaica’s men’s and women’s rugby sevens sides for next year’s Junior Pan American ...
A study has revealed the presence of dangerous forever chemicals in bands sold by top brands. Interestingly, the more ...
Rhonda James was skeptical when her husband ordered a weighted blanket for her online. But five minutes after she wrapped it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback